Dr. Jeffrey Anderson, MD

• Cardiology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard Medical School

  Medical School, 1972

• Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease among Patients Undergoing Coronary Angiography, 2008-07-10

• Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction, 2020-05-21

• Genetics InFormatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis (DVT): Rationale and Study Design, 2011-05-24

• The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart Study, 2015-10-19

• Joint Effects of Common Genetic Variants from Multiple Genes and Pathways On the Risk of Premature Coronary Artery Disease, 2010-06-18

• Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial, 2023-09-11

• A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL]), 2013-04-26

• Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population Sociodemographic Factors, Blood Group Type, and Risk of COVID-19, 2021-04-05

• Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings, 2009-08-18

• Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis, 2022-04-01

• Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience, 2023-05-03

• Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience, 2022-08-17

• Reduced-FunctionCYP2C19Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI: A Meta-Analysis, 2010-10-27

• A simplified definition of diastolic function in sepsis, compared against standard definitions, 2019-02-20

• The history and geographic distribution of a KCNQ1 atrial fibrillation risk allele, 2021-11-08

• A highly predictive cardiac positron emission tomography (PET) risk score for 90-day and one-year major adverse cardiac events and revascularization, 2022-12-19

• Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience, 2022-12-22

• Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial, 2021-12-09

• Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study, 2009-12-15

• Circulating Levels of 25Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies, 2012-11-13

• Pharmacogenetic Warfarin Dose Refinements Remain Significantly Influenced by Genetic Factors after One Week of Therapy, 2011-12-21

• Economics and outcomes of sotalol in-patient dosing approaches in patients with atrial fibrillation, 2022-01-05

• Effect of Genetic Variants, EspeciallyCYP2C9andVKORC1, on the Pharmacology of Warfarin, 2012-10-06

• Association of Variation in the Chromosome 9p21 Locus with Myocardial Infarction versus Chronic Coronary Artery Disease, 2008-12-01